2,3,4,6-tetrachlorophenol has been researched along with Cystic Fibrosis of Pancreas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kerem, E | 1 |
Becq, F | 1 |
Bridges, RJ; Devor, DC; Frizzell, RA; Singh, AK | 1 |
2 review(s) available for 2,3,4,6-tetrachlorophenol and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Chlorophenols; Codon, Nonsense; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Milrinone; Molecular Chaperones; Mutation; Phenotype; Phosphodiesterase Inhibitors; Xanthines | 2005 |
On the discovery and development of CFTR chloride channel activators.
Topics: Benzimidazoles; Chlorophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Design; Flavonoids; Humans; Ion Channel Gating; Molecular Structure; Mutation | 2006 |
1 other study(ies) available for 2,3,4,6-tetrachlorophenol and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Psoralens: novel modulators of Cl- secretion.
Topics: Animals; Atropine; Benzimidazoles; Calcium; Carbachol; Cell Line; Chloride Channels; Chlorides; Chlorophenols; Colon; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Ficusin; Humans; Intestinal Mucosa; Ion Channel Gating; Methoxsalen; Mice; Potassium; Rats; Trachea; Trioxsalen | 1997 |